Figure 1: Treatment timeline with chest computed tomography (CT) and brain magnetic resonance images (MRI) on osimertinib. (IMAGE)

Impact Journals LLC

Figure 1: Treatment timeline with chest computed tomography (CT) and brain magnetic resonance images (MRI) on osimertinib.

Caption

Figure 1: Treatment timeline with chest computed tomography (CT) and brain magnetic resonance images (MRI) on osimertinib. (A) Pretreatment CT chest, demonstrating 18 mm spiculated mass in the left upper lobe (LUL). (B) CT chest following 12 days of Osimertinib treatment, showing decreased size of LUL mass. (C) Pretreatment brain MRI showing no acute abnormalities (axial). (D) Pretreatment brain MRI showing no acute abnormalities (sagittal).

Credit

2024 Bhatia et al.

Usage Restrictions

Original Content

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.